Rajesh K. Malik

Rajesh K. Malik

Cardiac Electrophysiology | Cardiology

3920 Bee Ridge Rd
Unit F
Sarasota, FL 34233

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Quality of life and clinical outcomes after large-bore mechanical thrombectomy for submassive pulmonary embolism.

Quality of life and clinical outcomes after large-bore mechanical thrombectomy for submassive pulmonary embolism.

Journal: Journal of vascular surgery. Venous and lymphatic disorders

Published: October 13, 2025

Mechanical thrombectomy with the InThrill device for thrombosed hemodialysis access: A single center experience.

Mechanical thrombectomy with the InThrill device for thrombosed hemodialysis access: A single center experience.

Journal: The journal of vascular access

Published: August 24, 2024

Large-bore Aspiration Thrombectomy for Acute Venous Thromboembolism.

Large-bore Aspiration Thrombectomy for Acute Venous Thromboembolism.

Journal: Surgical technology international

Published: November 24, 2021

Transcarotid Artery Revascularization and Advances in Vascular Surgery for Carotid Artery Disease.

Transcarotid Artery Revascularization and Advances in Vascular Surgery for Carotid Artery Disease.

Journal: Surgical technology international

Published: November 24, 2021

Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.

Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.

Journal: Cancer management and research

Published: March 30, 2021

Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer.

Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer.

Journal: International journal of cancer

Published: March 09, 2021

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Journal: Cancer medicine

Published: March 01, 2021

Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.

Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: November 13, 2020

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy.

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy.

Journal: Journal for immunotherapy of cancer

Published: August 17, 2020

Touch-up and recurrence rates after voltage mapping for verification of pulmonary vein isolation following cryoablation of paroxysmal atrial fibrillation.

Touch-up and recurrence rates after voltage mapping for verification of pulmonary vein isolation following cryoablation of paroxysmal atrial fibrillation.

Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Published: November 13, 2018

Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Journal: The New England journal of medicine

Published: October 04, 2018

Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease.

Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease.

Journal: Annals of vascular surgery

Published: September 25, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026